← FDA Drug Approvals (Drugs@FDA)

BACLOFEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2023-02-22

Drug application

FDA Application #

ANDA217324

Application type

Abbreviated New Drug Application (Generic)

Brand name

BACLOFEN

Generic name

BACLOFEN

Active ingredients

BACLOFEN

Dosage form

INJECTABLE

Route

INTRATHECAL

Marketing status

Prescription

Sponsor

RUBICON RESEARCH

Manufacturer

Nexus Pharmaceuticals LLC

First approval

2023-02-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown